KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Enterprise Value (2016 - 2026)

Quest Diagnostics' Enterprise Value history spans 18 years, with the latest figure at -$93.0 million for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 40.0% to -$93.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$93.0 million, a 40.0% increase, with the full-year FY2025 number at -$384.0 million, up 25.29% from a year prior.
  • Enterprise Value hit -$93.0 million in Q1 2026 for Quest Diagnostics, up from -$384.0 million in the prior quarter.
  • Over the last five years, Enterprise Value for DGX hit a ceiling of -$49.0 million in Q2 2023 and a floor of -$751.0 million in Q2 2022.
  • Historically, Enterprise Value has averaged -$367.1 million across 5 years, with a median of -$351.0 million in 2025.
  • Biggest five-year swings in Enterprise Value: soared 93.48% in 2023 and later crashed 920.9% in 2024.
  • Tracing DGX's Enterprise Value over 5 years: stood at -$238.0 million in 2022, then tumbled by 156.3% to -$610.0 million in 2023, then rose by 15.74% to -$514.0 million in 2024, then rose by 25.29% to -$384.0 million in 2025, then surged by 75.78% to -$93.0 million in 2026.
  • Business Quant data shows Enterprise Value for DGX at -$93.0 million in Q1 2026, -$384.0 million in Q4 2025, and -$351.0 million in Q3 2025.